Although the United States continues to have the safest food supply in the world, foodborne illness affects a significant number of Americans annually (9) . Salmonella enterica infection is the second leading cause of foodborne illness, with an estimated 1.4 million cases of resulting gastroenteritis every year (6) . The economic impact of salmonellosis is substantial, with an estimated annual cost of over $3.5 billion due to loss of work productivity, medical care, and loss of life (1) . Salmonellosis is frequently attributed to the consumption of contaminated food products such as poultry meat, beef, pork, and eggs. Cattle are a frequent reservoir for Salmonella, and novel strategies aimed at minimizing shedding of Salmonella are important for reducing the incidence of foodborne illness.
Iron limitation is an essential antimicrobial component of the immune system. Iron-binding proteins (particularly transferrin and lactoferrin) bind virtually all free iron in mammalian cells and tissues, thereby rendering iron unavailable to most microorganisms (13) . However, some pathogenic bacteria can acquire iron directly from these iron-binding proteins or through the use of siderophores (13) . A variety of preventive and therapeutic strategies for combating bacterial infections have been developed that act by interfering with microbial iron acquisition and utilization. Gallium is a semimetal that accumulates in inflamed tissue, macrophages, neutrophils, and some bacteria (3) . The antimicrobial effects of gallium are related to its ability to be a nonfunctional iron mimic. Bacteria acquire gallium instead of iron and incorporate gallium into metabolic pathways and enzymes that require iron. Many of these enzymes, particularly ribonucleotide reductase, are critical for cell cycle regulation and DNA synthesis in bacteria. The net result is inhibition of DNA synthesis and bacterial replication and ultimately bacterial cell death (3) . In recent studies, gallium exhibited bactericidal activity in vitro and in vivo against numerous pathogenic bacteria, including Rhodococcus equi, Mycobacterium tuberculosis, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa (2, 5, 7, 8, 11) . Gallium maltolate (GaM), a complex of gallium and maltol that was developed by one of the authors (L.R.B.), provides high gallium bioavailability in humans and a variety of other mammalian species and has not been associated with toxicity or gastrointestinal irritation (3). In the present study, we hypothesized that GaM would significantly reduce in vitro growth of Salmonella in pure culture and in mixed culture from ruminal fluid and that oral administration of GaM would significantly reduce the numbers of Salmonella cells shed in the feces of cattle.
MATERIALS AND METHODS
Pure culture growth studies. Salmonella enterica serovar Newport was grown at 37uC overnight in tryptic soy broth (TSB). Bacteria were washed three times with phosphate-buffered saline (PBS), and approximately 1 | 10 6 CFU ml 21 was inoculated into M9 minimal medium (12) (control) or M9 supplemented with 50, 150, 250, or 500 mM GaM. Bacteria were grown with rotation at 37uC under aerobic conditions. Bacterial populations were determined by 10-fold serial dilutions and direct plating onto tryptic soy agar plates at 0, 2, 4, 6, 8, 12, and 24 h.
Growth studies for mixed cultures of ruminal fluid. Salmonella Newport was grown overnight and washed in PBS as described above. Ruminal fluid cultures were grown by combining the ruminal fluid (1:3) from a single cannulated animal with an anoxic basal medium (4, 10) . The resultant individual suspensions were transferred to 150-mm Balch tubes (Bellco Glass, Vineland, NJ) (10 ml per tube), and 50, 150, 250, and 500 mM GaM was added to each of the tubes (except the control tube). Tubes were then sealed with rubber stoppers with aluminum crimps and incubated for 24 h at 37uC. Bacterial populations were determined by direct plating and by plating dilutions onto xylose lysine deoxycholate (XLD) agar plates, and colonies were counted at 0, 2, 4, 6, 8, 12, and 24 h.
Animals and experimental design. Fourteen Holstein steers (mean body weight, 650 kg) were used in this study. Before initiation of treatment, all animals were housed in a single outdoor pen with ad libitum access to water and were fed as a group at approximately 2.5% of their body weight once daily. Steers were adapted to an 80:20 concentrate:forage ration over 14 days and maintained on that ration for the duration of the study. The concentrate portion of the ration was commercial cattle feed containing 12% crude protein, 4.5% crude fat, vitamins, and minerals. The forage and fiber portion of the diet was provided by grass hay and cottonseed hulls in the commercial cattle feed. Steers were randomly assigned to receive 0 g of GaM (control), 6.5 g of GaM (low dose, designed to achieve an approximate concentration of 250 mM GaM in the rumen), or 13.0 g of GaM (high dose, designed to achieve an approximate concentration of 500 mM GaM in the rumen). Treatment starting dates were staggered by approximately 1 week, for the two groups of steers (seven steers per group) in the experiment. Group 1 consisted of two control animals, three low-dose animals, and two high-dose animals. Group 2 consisted of three control animals and four high-dose animals.
Screening and challenge. Before the experimental infection, animals were screened for fecal shedding of Salmonella. Salmonella-positive samples were evaluated for serogroup with the slide agglutination method and Salmonella antiserum (Difco Laboratories, BD, Sparks, MD). Both groups were experimentally infected by oral gavage with 550 ml of TSB containing a cocktail of two S. enterica serovars: Newport (novobiocin and tetracycline resistant) and Montevideo (novobiocin resistant). For group 1, the mixture contained approximately 4. Treatment and sampling. At the initiation of treatment, cattle were placed in individual pens and remained there for the duration of the study. For group 1, both control animals were given an empty bolus, three treatment animals were given a bolus containing the low dose of GaM, and two treatment animals were given the high dose of GaM. For this group, the first GaM treatment was given 60 h after experimental infection. However, quantifiable levels of Salmonella were undetectable in one of the steers at the time treatment was initiated (time 0) and began dropping off in the other steers at subsequent time points. Because of the difficulties arising from experimental infection in group 1, we eliminated the low dose of GaM from the treatment regimen of group 2 and initiated treatment 24 h after experimental infection. In group 2, the three control animals were given an empty bolus, and the four treatment animals were given a bolus containing a high dose of GaM.
Starting at the initiation of treatment, fecal samples were obtained from steers in both groups by rectal palpation at 12-h intervals for 60 h and processed for qualitative and quantitative analysis of Salmonella. Sixty hours after initiation of treatment, steers from both groups were euthanized. Luminal contents and tissues were aseptically harvested from the rumen, jejunum, spiral colon, cecum, and rectum. The luminal contents were processed as described below for quantitative and qualitative analysis of the challenge strains of Salmonella, and tissue samples were enriched as described below and plated for qualitative analysis. 2) and incubated at 25uC for 2 h, at 42uC for 6 h, and then overnight at 5uC. Salmonella populations were quantified by direct plating of the sample plus TSB-phosphate mixture (before enrichment) onto XLD agar supplemented with novobiocin (25 mg ml 21 for Salmonella Newport and Salmonella Montevideo) or novobiocin and tetracycline (32 mg ml 21 for Salmonella Newport alone) using a commercially available spiral plater (Spiral Biotech Autoplate 4000, Advanced Instruments, Inc., Norwood, MA). Plates were incubated overnight at 37uC. Black colonies exhibiting typical Salmonella morphology were counted, and populations were calculated. For qualitative determination of Salmonella, samples were enriched in TSB-phosphate. A 200-ml sample of the enriched culture was transferred to 5 ml of Rappaport-Vassiliadis R10 broth, incubated an additional 24 h at 42uC, and subsequently plated onto brilliant green agar (BGA) supplemented with novobiocin (25 mg ml 21 for qualitative analysis of both Salmonella Newport and Salmonella Montevideo) or novobiocin and tetracycline (32 mg ml 21 for qualitative analysis of Salmonella Newport alone). After incubation at 37uC for 24 h, BGA plates with pink colonies exhibiting typical Salmonella morphology were considered positive. Random colonies from BGA plates were confirmed biochemically by plating on lysine and triple sugar iron agars. Unless otherwise noted, all reagents and antibiotics were obtained from Sigma Chemical (St. Louis, MO) and media were obtained from Difco Laboratories (Detroit, MI).
Culture of
Statistical analysis. All data were analyzed using SAS version 9.1.3 (SAS Institute, Cary, NC). Quantitative data from in vitro culture studies, fecal samples, and luminal contents were log transformed and analyzed using the GLIMMIX procedure, with treatment, time, and treatment per time interactions included in the model. For some samples, Salmonella was recovered only from enriched specimens, indicating that levels were below our limit of detection (,20 CFU g 21 ). Because of the inherent assumption that these samples contained Salmonella but at levels below the limit of detection (rather than assuming total absence of Salmonella) and the inability to take the log of 0, we added the limit of detection to all quantitative data before statistical analysis. Qualitative data from feces, luminal contents, and tissues were analyzed with chisquare frequency tables. Results were considered significant at the 0.05 level for the type I error.
RESULTS AND DISCUSSION
The objective of this project was to investigate the potential use of GaM to reduce fecal shedding of Salmonella in cattle. Because gallium interferes with iron-dependent metabolic pathways and suppresses growth of numerous species of pathogenic bacteria (2, 5, 7, 8, 11), we hypothesized that GaM would suppress the growth of Salmonella Newport in a similar manner. The levels of Salmonella Newport at 0, 2, 4, 6, 8, 12, and 24 h were compared when cultivated in M9 supplemented with various concentrations of GaM and in M9 without GaM ( Table 1) . The presence of GaM in the culture medium significantly inhibited (P , 0.05) growth of Salmonella Newport in a time-and dose-dependent manner. Significant effects on growth were not observed after 2 h of incubation. After 4, 6, 8, and 12 h of incubation, there were significantly fewer Salmonella Newport cells present in M9 supplemented with all concentrations of GaM compared with cultures grown in M9 alone. However, although there were significantly fewer Salmonella Newport cells present in M9 supplemented with 250 and 500 mM GaM after 24 h of incubation, there were no significant differences in numbers of Salmonella Newport grown in M9 supplemented with 50 and 150 mM GaM compared with Salmonella Newport grown in M9 alone. These findings indicate that the presence of GaM significantly inhibits the growth of Salmonella Newport in pure culture but that higher concentrations of GaM are needed to maintain this inhibition after 12 h.
Similar observations were made when the experiments were conducted in mixed culture of ruminal fluid ( Table 2) . After 2 h of incubation, there were significantly fewer (P , 0.05) Salmonella Newport cells present in mixed culture of ruminal fluid supplemented with 250 and 500 mM GaM (but not in cultures with 50 and 150 mM GaM) compared with Salmonella Newport grown in mixed culture of ruminal fluid alone. After 4 h of incubation, there were significantly fewer Salmonella Newport cells present in mixed culture of ruminal fluid supplemented with 150, 250, and 500 mM GaM (but not 50 mM GaM) compared with Salmonella Newport in mixed culture of ruminal fluid alone. This trend continued through the 12-h sampling time. However, after 24 h there were no significant differences in numbers of Salmonella Newport cells between mixed culture of ruminal fluid supplemented with any concentration of GaM and mixed culture of ruminal fluid alone. The lack of significant differences in numbers of Salmonella Newport cells between mixed culture of ruminal fluid alone and mixed culture of ruminal fluid supplemented with various concentrations of GaM after 24 h of incubation is not due to the ability of Salmonella Newport to overcome the inhibitory effects of GaM but rather to decreasing numbers of Salmonella Newport cells in the mixed culture of ruminal fluid alone.
Because of the antimicrobial effects on Salmonella Newport found in the in vitro portion of this study, we investigated the ability of orally administered GaM to control Salmonella Newport in experimentally infected cattle. Because the in vitro data revealed that the highest level of inhibition occurred in media supplemented with 250 and 500 mM GaM, we gave the steers boluses of GaM that would deliver enough GaM to attain an approximate concentration of 250 and 500 mM GaM in the rumen. At the time of prescreening, all steers were shedding low levels of Salmonella (subsequently determined to be Salmonella Newport) in their feces. Before initiating the study, we experimentally infected the steers with approximately 5 |10
10 CFU of Salmonella Newport (the same strain used to generate preliminary data for this study) to establish an appropriate challenge dose for use in the study. We collected samples from these steers 24 h after experimental infection and found that all animals were shedding low levels of quantifiable Salmonella in their feces. However, within 48 h none of the steers were shedding quantifiable levels of Salmonella. Thus, for the current study we opted to challenge the steers with a cocktail of Salmonella Newport and Salmonella Montevideo at an approximately 10-fold higher level (i.e., 5 | 10 11 CFU), which resulted in an adequate challenge (i.e., steers shed quantifiable levels of Salmonella for at least 48 h postinfection).
After experimental infection of group 1, fecal shedding appeared to be intermittent, with levels of quantifiable Salmonella falling below the limit of detection at some time points and then rising again at other time points. Unfortunately, quantifiable levels of Salmonella were undetectable in one of the control steers at the time treatment was initiated and in the other control steer at 12 h, making it difficult to determine any treatment effect. We attributed this lack of quantifiable results to the length of time between experimental infection and initiation of treatment; all animals were consistently shedding quantifiable levels of Salmonella at 48 h postinfection. Thus, for group 2 we initiated treatment 24 h after experimental infection because steers in this group shed quantifiable levels of Salmonella in their feces throughout the study, and we subsequently analyzed the data for this group separately from the data for group 1. The treatment with the low dose of GaM used for group 1 was dropped from the group 2 experiment; only the high dose of GaM was administered to group 2 steers. The variability between steers was so large that we found no significant differences in fecal shedding between control steers and treated steers in either group 1 (Fig. 1) or group 2 (Fig. 2) . Likewise, we found no significant differences when comparing levels of Salmonella in luminal contents from control steers and treated steers in groups 1 and 2 (Table 3) . With respect to qualitative shedding of Salmonella in feces, luminal contents, and tissues, we observed no pattern for control steers and treated steers in the frequency of positive or negative samples in group 1 (Table 4) or group 2 (Table 5) . Because of the shedding and/or colonization problems observed in group 1 and the substantial variability among animals in both groups, the statistical power of this study was limited. Therefore, although results of this study indicate that GaM was not effective for reducing fecal shedding of Salmonella in experimentally infected cattle, it may be premature to dismiss GaM as a potential preharvest antiSalmonella treatment. Another potential reason for the negative findings in this study is that GaM has high oral bioavailability and is rapidly absorbed by the gastrointestinal tract and distributed throughout the tissues of the body (3). Thus, less gallium may have been available in the gastrointestinal tract because of absorption, resulting in little to no effect of gallium on the presence or level of Salmonella throughout the gastrointestinal tract. We used GaM in this study because preliminary data revealed that GaM had antimicrobial properties against Salmonella Newport in vitro and because GaM has limited toxicity in humans and other mammalian species (3). However, in future studies another formulation of gallium (such as gallium nitrate) that is not as readily absorbed from the gastrointestinal tract may be more effective for reducing Salmonella populations in the luminal contents and feces of infected cattle.
